Patrick Zweidler-McKay

Company: ImmunoGen
Job title: Executive Medical Director
Seminars:
Sharing Results from SORAYA: A Phase III Trial of Mirvetuximab soravtansine in Platinum Resistant, FRα-high Ovarian Cancer 3:30 pm
Discussing efficacy and safety of MIRV in FR-alpha high, platinum resistant ovarian cancer Outlining the evolution of the companion diagnostics and impacts on trials Sharing information about on-going trials and next stepsRead more
day: day 2- pm